Primary Site >> Colorectal Cancer
Gene >> PAM
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells. PMID: 3583642 |
Ref: Enhancement of melphalan (L-PAM) toxicity by reductive metabolites of 1-methyl-2-nitroimidazole, a model nitroimidazole chemosensitizing agent. PMID: 2260990 |
Ref: Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver. PMID: 10789721 |
Ref: Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant. PMID: 15685548 |
Ref: Comparative Analysis of Cluster Validity Indices in Identifying Some Possible Genes Mediating Certain Cancers. PMID: 27481591 |
Ref: Gene expression profiling of colorectal tumors and normal mucosa by microarrays meta-analysis using prediction analysis of microarray, artificial neural network, classification, and regression trees. PMID: 24959000 |
Ref: Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients. PMID: 26848797 Ref: Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System. PMID: 27412426 |